Nabis Holdings Announces 2 Additional Investments in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
63
Nabis Holdings Announces 2 Additional Investments in Municipally Approved Properties in Michigan - Taking the Total of Provisioning Centers to 7 in One of the Largest Medical License Cannabis States

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, British Columbia, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Innovative Properties Inc. d/b/a Nabis Holdings (CSE:NAB; OTC: INNPF, FRA:7IP) (“ Nabis ” or the “ Company ”) is pleased to announce that the Company has entered into a binding Letter of Intent (“LOI”) to invest in an additional two strategically located properties that have municipal approvals for provisioning centres in Michigan, USA for a total consideration of USD $6 million. The provisioning centers are located strategically in the City of Detroit and one property in Bay City (“Properties”). The existing municipal approvals with respect to the properties will expedite the State licensing process for dispensary locations under the new recreational cannabis regime in Michigan. These provisioning centers previously operated prior to the new Michigan State regulatory regime and generated unaudited historic gross revenues of approximately USD $9 million in 2018, with an approximate 30% adjusted EBITDA margin or approximately USD  $3 million. Assuming the closing of the acquisition, Nabis expects the acquired provisioning centers to generate approximately USD $10 million annual revenue in 2019 and USD $18 million revenue in 2020, with estimated 30% adjusted EBITDA margins. These two properties would take Nabis’ total to seven provisioning centers in Michigan assuming closing of the five properties previously announced on January 17, 2019. The Company is currently evaluating additional municipally approved locations in the State and in other limited license States.

The revenue and adjusted EBITDA guidance provided herein is for illustrative purposes for investors to assess the value of the transaction and is subject to the assumptions that the Company will receive the required State of Michigan license for the retail sale of cannabis, the price for cannabis and related products in Michigan State will remain consistent with current pricing, consumer demand for the products remains strong; retention of key employees and management; changes in State and/or municipal regulations of retail operations and changes in government regulations generally with respect to the sale of Cannabis.

A finder’s fee will be payable in regards to this transaction to an unrelated third party. The LOI is subject to definitive documentation and the transaction is expected to close in March 2019. 

About Nabis Holdings

Nabis Holdings is a Canadian investment issuer that invests in high quality cash flowing assets across multiple industries, including real property, securities, cryptocurrency, and all aspects of the U.S. and international cannabis sector. Led by two of the co-founders of MPX Bioceutical (CSE:MPX), one of the largest takeovers in the U.S. Cannabis space to date, the company has proven track record in emerging markets to create significant shareholder value. The Company is focused on investing across the entire vertically integrated aspects of the space with a focus on  revenue generation, EBITDA and growth.

ON BEHALF OF THE BOARD OF DIRECTORS

“Shay Shnet”

Shay Shnet CEO and Director

For inquiries, please contact 604-687-7130 or email info@nabisholdings.com .

The CSE does not accept responsibility for the adequacy or accuracy of this release.

All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The risks are without limitations: that the acquisitions will be completed by the Company or completed upon the terms disclosed; the price for cannabis and related products will remain consistent and the consumer demand remains strong; availability of financing to the Company to develop the retail locations; retention of key employees and management; changes in State and/or municipal regulations of retail operations and changes in government regulations generally. Important factors that could cause actual results to differ, materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Ontario Securities Commission and the Alberta Securities Commission.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Device Transforms Golf Ball Pickup Experience

Updated Category News Views 451

Revolutionary Device Enhances Golf Ball Retrieval Inventors are always looking for ways to simplify tasks and improve our experiences. One innovative creator has unveiled a practical solution for golfers: the BALL PICK. This device addresses a common struggle faced by golfers at all skill levels – the hassle of bending down to pick up golf balls. Imagine a device that...

Continue Reading
HCSC Introduces Simplified Health Care Coverage Alternative

Updated Category News Views 321

HCSC Launches a New Streamlined Health Care Coverage Option Health Care Service Corporation (HCSC) is thrilled to announce a new health plan designed to simplify the healthcare experience for its members. This innovative option is aimed at individuals looking for a more straightforward way to handle their healthcare expenses. Simplified Monthly Billing with No Deductibles...

Continue Reading
Desvelados Mexican Cantina: A Flavorful New Gem in Town

Updated Category News Views 314

Desvelados Mexican Cantina Is Now Open In a vibrant celebration, Desvelados Mexican Cantina has opened its doors, bringing authentic Mexican flavors to the local dining scene. This lively cantina invites food lovers to indulge in an array of mouthwatering dishes, making it the perfect spot for gatherings with friends and family. Dining Experience at Desvelados Upon...

Continue Reading
Promising Results from Arcus Biosciences’ Casdatifan in Cancer Trials

Updated Category News Views 67

Groundbreaking Developments in Cancer Treatment Arcus Biosciences, Inc. (NYSE:RCUS), a leader in biopharmaceutical innovation, has recently presented compelling clinical data regarding their leading candidate, casdatifan, a HIF-2a inhibitor that shows outstanding promise in treating metastatic kidney cancer. The data was shared by Dr. Toni K. Choueiri at a significant...

Continue Reading
Understanding Options Movement in Johnson & Johnson Stock

Updated Category News Views 203

Key Insights on Johnson & Johnson Options Activity Investors are paying close attention to the options market for Johnson & Johnson (NYSE: JNJ), as recent activities indicate a bearish stance among high-profile investors. Understanding these movements can be valuable for retail traders looking to navigate the complexities of stock trading. Recent Options Trends Recently,...

Continue Reading